Prevention of growth of human lung carcinoma cells and induction of apoptosis by a novel phenoxazinone, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one

Anti-Cancer Drugs

Volumn 12, Issue 4, 2001, Pages 377-382

  Abe, Akihisa ^a   Yamane, Mototeru ^a   Tomoda, Aklo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Dose dependency; Growth inhibition; Lung carcinoma cell lines; Phenoxazinone

Indexed keywords

2 AMINO 4,4ALPHA DIHYDRO 4ALPHA,7 DIMETHYL 3H PHENOXAZIN 3 ONE; ANTINEOPLASTIC AGENT; DACTINOMYCIN; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DNA DEGRADATION; DRUG EFFECT; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL DIVISION; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; OXAZINES; TUMOR CELLS, CULTURED;

EID: 0035009262     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200104000-00011     Document Type: Article

References (13)

1. 1H NMR spectroscopy. J Mol Biol 1996; 262: 53-68.
2. 2. Goldberg IH, Friedman PA. Antibiotics and nucleic acids. Annu Rev Biochem 1971; 40: 775-810.
3. 3. Tomoda A, Hamashima H, Arisawa M, Kikuchi T, Tezuka Y, Koshimura S, Phenoxazinone synthesis by human hemoglobin. Biochim Biohys Acta 1992; 1117: 306-14.
4. 4. Tomoda A, Arai S, Ishida R, Shimamoto T, Ohyashiki K. An improved method for rapid preparation of 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one, a novel antitumor agent. Bioorg Med Chem Lett 2001; 7: in press.
5. 5. Ishida R, Yamanaka S, Kawai H, et al. Antitumor activity of 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one, a novel phenoxazine derivative produced by the reaction of 2-amino-5-methylphenol with bovine hemolysate. Anti-Cancer Drugs 1996; 7: 591-5.
6. 6. Mori H, Honda K, Ishida R, Nohira T, Tomoda A. Antitumor activity of 2-amino4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anti-Cancer Drugs 2000; 11: 653-7.
7. 7. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 1997; 44: 1299-305.
8. 8. Lokshin A, Levitt ML. Effect of suramin on squamous differentiation and apoptosis in three human non-small cell lung cancer cell lines. J Cell Biochem Suppl 1996; 24: 186-97.
9. 9. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2353-62.
10. 10. Chang MP, Baldwin RL, Bruce C, Wisnieski BJ. Second cytotoxic pathway of diphtheria toxin suggested by nuclease activity. Science 1989; 246: 1165-8.
11. 11. Wright SC, Kumar P, Tam AW, et al. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 1992; 48: 344-55.
12. 12. Nicolau KC, Stabila P, Esmaeli-Azad B, Wrasidlo W, Hiatt A. Cell-specific regulation of apoptosis by designed enediynes. Proc Natl Acad Sci USA 1993; 90: 3142-6.
13. 13. Motohashi N. Test for anti-tumor activities of phenotiazines and phenoxazines [In Japanese with English abstract]. Yakugaku-Zassi 1983; 103: 364-71.